Stay updated on Tiragolumab Combo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.

Latest updates to the Tiragolumab Combo in Stage II Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the old funding notice and Revision: v3.4.1.SummaryDifference0.8%

- Check19 days agoChange DetectedAdded a site-wide notice about a lapse in government funding that may affect updates, processing, and responses, with guidance to check status. Updated the revision version to v3.4.1.SummaryDifference0.9%

- Check26 days agoChange DetectedGlossary display is now available and the history uses green for additions and red for deletions with color-coded changes. The revision badge updates to v3.4.0 and No FEAR Act Data labeling appears on the page.SummaryDifference1.0%

- Check40 days agoChange DetectedNew revision entry v3.3.4 appears in the Record History, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry, Revision: v3.3.3, has been added to the Record History. The HHS Vulnerability Disclosure and Revision: v3.3.2 links have been removed.SummaryDifference0.2%

- Check90 days agoChange DetectedThe record history shows a new revision entry (v3.3.2) and a deletion of an earlier revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tiragolumab Combo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.